相关实验视频

Updated: Jun 16, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

伊诺图祖马布臭加米辛的安全性评估:基于FAERS数据库的药监测研究

Xueyu Duan¹, Yongkun Deng, Lei Li

¹Department of Pharmacy, The 926th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Kaiyuan, Yunnan, China.

International journal of surgery (London, England)

|May 13, 2025

概括

伊诺图祖马布奥佐加米辛 (InO) 的使用与严重的不良事件有关,如VOD,感染和发烧性中性质衰竭. 警监测对于在接受INO治疗的患者中管理这些风险至关重要.

科学领域:

药物监督药物监督药物监督
在瘤学瘤学.
血液学血液学血液学

背景情况:

伊诺图祖马布 (Inotuzumab ozogamicin,简称InO) 是一种针对性疗法,最近在市场上推出.
市场后监测对于识别现实世界药物不良事件 (ADEs) 至关重要.

研究的目的:

通过使用大型不良事件报告数据库,调查与INO相关的现实世界ADE.
通过信号检测方法识别和量化INO的安全信号.

主要方法:

从FAERS数据库 (2004Q1-2024Q3) 中分析INO相关的ADE报告.
应用报告几率比率 (ROR) 方法来检测因诺相关的ADE信号.

主要成果:

分析了1007名患者和2725名不良事件.
确定的重要安全信号包括VOD (ROR=486.02),感染 (ROR=3.27) 和发烧性中性质减退 (ROR=20.43).
还检测到新出现的ADEs,如败血症 (ROR=7.14),细胞因子释放综合征 (ROR=36.78) 和移植对宿主疾病 (ROR=62.21).

结论:

InO与显著的ADEs有关,特别是VOD,感染和发烧性中性质衰竭.
这些并发症的早期发现和管理至关重要.
建议在接受InO.O.的患者中采取积极的监测策略.

关键词:

公平的人是公平的.ROROR ROR 这是一个很好的例子.药物不良事件是药物不良事件.伊诺图祖马布 (inotuzumab) 是一种奥佐加米辛的药物.

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos

Rapid Evaluation of Toxicity of Chemical Compounds Using Zebrafish Embryos

Published on: August 25, 2019

相关概念视频

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...